Search for topics, articles, videos, research, etc...
Hit enter to search or ESC to close
Are you looking for:
MJFF Publications
Donate Now
Access Resources

MJFF Publications
5531 - 5540 of 7942 Results
Title
Year
  • Year
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • 2018
  • Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein
    2018
    OPEN
    Title: Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type α-synuclein
    Author(s): Sudhakar R. Subramaniam, Iddo Magen, Nicholas Bove, Chunni Zhu, Vincent Lemesre, Garima Dutta, Chris Jean Elias, Henry A. Lester, Marie‐Françoise Chesselet
    Journal Name: Neurobiology of Disease
    Publisher: Elsevier BV
    Vol: 117
    Issue #:
    Start Page: 170
    End Page: 180
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.nbd.2018.05.018
    Best OA location URL: https://europepmc.org/articles/pmc6051902?pdf=render
    Citation Count: 31
  • Gene Therapy Strategies to Restore ER Proteostasis in Disease
    2018
    RESTRICTED
    Title: Gene Therapy Strategies to Restore ER Proteostasis in Disease
    Author(s): Vicente Valenzuela, Kasey L. Jackson, S. Pablo Sardi, Claudio Hetz
    Journal Name: Molecular Therapy
    Publisher: Elsevier BV
    Vol: 26
    Issue #: 6
    Start Page: 1404
    End Page: 1413
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.ymthe.2018.04.004
    Best OA location URL: https://doi.org/10.1016/j.ymthe.2018.04.004
    Citation Count: 35
  • Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?
    2018
    RESTRICTED
    Title: Longitudinal studies of botulinum toxin in cervical dystonia: Why do patients discontinue therapy?
    Author(s): H. A. Jinnah, Cynthia Comella, Joel S. Perlmutter, Codrin Lungu, Mark Hallett
    Journal Name: Toxicon
    Publisher: Elsevier BV
    Vol: 147
    Issue #:
    Start Page: 89
    End Page: 95
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.toxicon.2017.09.004
    Best OA location URL: https://europepmc.org/articles/pmc5839920?pdf=render
    Citation Count: 49
  • Mechanism of parkin activation by PINK1
    2018
    OPEN
    Title: Mechanism of parkin activation by PINK1
    Author(s): Christina Gladkova, Sarah Maslen, Mark Skehel, David Komander
    Journal Name: Nature
    Publisher: Springer Science and Business Media LLC
    Vol: 559
    Issue #: 7714
    Start Page: 410
    End Page: 414
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41586-018-0224-x
    Best OA location URL: https://europepmc.org/articles/pmc6071873?pdf=render
    Citation Count: 294
  • mGlu4 allosteric modulation for treating Parkinson's disease
    2018
    RESTRICTED
    Title: mGlu4 allosteric modulation for treating Parkinson's disease
    Author(s): Delphine Charvin
    Journal Name: Neuropharmacology
    Publisher: Elsevier BV
    Vol: 135
    Issue #:
    Start Page: 308
    End Page: 315
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.neuropharm.2018.03.027
    Best OA location URL:
    Citation Count: 27
  • The spectrum of “off” in Parkinson's disease: What have we learned over 40 years?
    2018
    RESTRICTED
    Title: The spectrum of “off” in Parkinson's disease: What have we learned over 40 years?
    Author(s): Kelvin L. Chou, Mark Stacy, Tanya Simuni, Janis M. Miyasaki, Wolfgang H. Oertel, Kapil D. Sethi, Hubert H. Fernández, Fabrizio Stocchi
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Vol: 51
    Issue #:
    Start Page: 9
    End Page: 16
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2018.02.001
    Best OA location URL:
    Citation Count: 108
  • Immunosuppressants and risk of Parkinson disease
    2018
    OPEN
    Title: Immunosuppressants and risk of Parkinson disease
    Author(s): Brad A. Racette, Anat Gross, Scott Martin Vouri, Alejandra Camacho‐Soto, Allison W. Willis, Susan Searles Nielsen
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Vol: 5
    Issue #: 7
    Start Page: 870
    End Page: 875
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.580
    Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.580
    Citation Count: 67
  • LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
    2018
    OPEN
    Title: LRRK2 activity does not dramatically alter α-synuclein pathology in primary neurons
    Author(s): Michael X. Henderson, Chao Peng, John Q. Trojanowski, Virginia M.‐Y. Lee
    Journal Name: Acta Neuropathologica Communications
    Publisher: Springer Science and Business Media LLC
    Vol: 6
    Issue #: 1
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s40478-018-0550-0
    Best OA location URL: https://actaneurocomms.biomedcentral.com/track/pdf/10.1186/s40478-018-0550-0
    Citation Count: 33
  • Partial ablation of the orexin field induces a sub-narcoleptic phenotype in a conditional mouse model of orexin neurodegeneration
    2018
    OPEN
    Title: Partial ablation of the orexin field induces a sub-narcoleptic phenotype in a conditional mouse model of orexin neurodegeneration
    Author(s): Sarah Wurts Black, Jessica D. Sun, Pamela Santiago, Alex Laihsu, Nikki Kimura, Akihiro Yamanaka, Ross Bersot, Paul S. Humphries
    Journal Name: Sleep
    Publisher: Oxford University Press (OUP)
    Vol: 41
    Issue #: 9
    Start Page:
    End Page:
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1093/sleep/zsy116
    Best OA location URL: https://academic.oup.com/sleep/article-pdf/41/9/zsy116/25714846/zsy116.pdf
    Citation Count: 11
  • Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson’s Disease and Their First-Degree Unaffected Relatives
    2018
    RESTRICTED
    Title: Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson’s Disease and Their First-Degree Unaffected Relatives
    Author(s): Avner Thaler, Efrat Kliper, Inbal Maidan, Talia Herman, Keren Rosenberg‐Katz, Noa Bregman, Tanya Gurevich, Tamara Shiner, Jeffrey M. Hausdorff, Avi Orr‐Urtreger, Nir Giladi, Anat Mirelman
    Journal Name: Brain Topography
    Publisher: Springer Science and Business Media LLC
    Vol: 31
    Issue #: 6
    Start Page: 1029
    End Page: 1036
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s10548-018-0653-8
    Best OA location URL:
    Citation Count: 25
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.